Bacopaside I | CAS No. 382148-47-2

Bacopaside I

Basic Information

View in Editor

CAS Number

382148-47-2

Molecular Formula

C46H74O20S

Molecular Weight

979.15 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Surfactants Anionic Surfactants

Polymers and Plastics Thermoplastics Polyolefins

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

Powder

SMILES

View in Editor

CC(=C[C@@H]1CO[C@]23C[C@]4(CO2)[C@@H]([C@H]3[C@@]1(C)O)CC[C@H]5[C@]4(CC[C@@H]6[C@@]5(CC[C@@H](C6(C)C)O[C@H]7[C@@H]([C@H]([C@H](CO7)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)COS(=O)(=O)O)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](O9)CO)O)O)C)C)C

InChI

InChI=1S/C46H74O20S/c1-21(2)14-22-16-59-46-19-45(20-60-46)23(37(46)44(22,7)54)8-9-28-42(5)12-11-29(41(3,4)27(42)10-13-43(28,45)6)64-40-36(66-38-33(52)30(49)25(15-47)62-38)35(24(48)17-58-40)65-39-34(53)32(51)31(50)26(63-39)18-61-67(55,56)57/h14,22-40,47-54H,8-13,15-20H2,1-7H3,(H,55,56,57)/t22-,23-,24+,25+,26-,27+,28-,29+,30+,31-,32+,33-,34-,35+,36-,37+,38+,39+,40+,42+,43-,44+,45+,46-/m1/s1

InChIKey

SKFWOYHZBNAJGA-YAOMZRCFSA-N

LogP

0.29040000000000954

Topological Polar Surface Area

299.28 Å²

Hydrogen Bond Donor/Acceptor

9 / 20

Complexity

1970

Safety Information

View Safety Information

Storage Conditions

2-8℃

Synonyms & References

English

Bacopaside I
BACOPA EXTRACT
BACOPASIDE I(AS)
A-D-glucopyranosyl-(1 inverted exclamation marku3)]-
A-L-arabinopyranoside]
Pseudojujubogenin 3-O-[α-L-arabinofuranosyl-(1→2)-[6-O-sulfo-β-D-glucopyranosyl-(1→3)]-α-L-arabinopyranoside]
36B8WUA361
Bacopaside I, (-)-
Bacopaside I (constituent of bacopa) [DSC]
Q27256548

MDL Number

MFCD07779135

FAQ

What regulatory guidelines apply to Bacopaside I (CAS: 382148-47-2)?

Bacopaside I (CAS: 382148-47-2) is subject to regulations under the Globally Harmonized System (GHS) for classification and labeling of chemicals. In the European Union, it falls under the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulation. In the United States, it is covered by the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) guidelines for chemical safety assessments and environmental releases.

Are there alternatives to Bacopaside I (CAS: 382148-47-2) in synthesis?

Yes, there are alternatives to Bacopaside I (CAS: 382148-47-2) in synthesis. Common substitutes include analogous compounds such as bacopaside II and other flavonoids. Alternative reagents like sodium borohydride and other reducing agents can be used as substitutes in the synthesis process to achieve similar functional groups.

What is the market or research trend for Bacopaside I (CAS: 382148-47-2)?

The market for Bacopaside I (CAS: 382148-47-2) is growing due to its potential antioxidant and neuroprotective properties. Research trends focus on its applications in natural health products and pharmaceuticals. Market dynamics include increasing demand from dietary supplements and cosmetics sectors. Price trends indicate steady growth as its bioactivity is recognized in various studies.

How should waste containing Bacopaside I (CAS: 382148-47-2) be handled?

Waste containing Bacopaside I (CAS: 382148-47-2) should be collected in appropriate containers and stored under controlled conditions to prevent degradation. Incineration is a common method for disposal, but professional waste disposal services are recommended to ensure compliance with environmental regulations. Proper handling includes ensuring all safety precautions are followed to protect the environment and human health.